The following resources provide examples of TGaS' thought leadership on a variety of pharmaceutical operations and business topics.
Showing 11 out of 61 available documents
Article, Sales
March 2016
PharmaVOICE
Sales reps will need to broaden their focus to include other healthcare stakeholders, acquire new skills, learn to integrate digital technologies into their sales process and become part of the solution to improving patient outcomes.
Article, Sales
March 2016
Pharmaceutical Commerce
By Nicolas Basta
Brian Voellmecke of TGaS Advisors is quoted in this article.
Article, Sales
March 2016
Pharmaceutical Commerce
Dramatic changes are seeping into how pharma companies manage diverse datasets.
Article, Sales
February 2016
PharmaVOICE
By PharmaVOICE
Curt Staab, Vice President at TGaS Advisors provides thoughts on growth in sales operations spending driven by changing biopharma challenges and priorities.
Article, Sales
December 2015
TGaS® Advisors' study predicts more sales ops budgeting--but more operational challenges.
Article, Sales
January 2013
PharmaVOICE
In the midst of a changing commercial landscape, pharma sales operations leaders are striving to produce vibrant organizations that develop and reward team members.
Article, Sales
January 2013
By Curt Staab, SVP, Emerging Life Sciences Network
In the midst of a changing commercial landscape, pharma sales operations leaders are striving to produce vibrant organizations that develop and reward team members.
Advisory Brief, Sales
August 2012
By Curt Staab, SVP, Emerging Life Sciences Network
TGaS Sales Operations presents a three-part prescription for planning, training and communications to convey value.
Advisory Brief, Sales
April 2012
By James Castello, VP, Incentive Compensation & Field Operations
Reps fear going from "hero to zero," but, say TGaS Sales Operations leaders, the real issues are perception and communication.
Article, Sales
June 2008
PharmaVOICE
PharmaVOICE talks to experts, inlcuding TGaS, about the need for a dramatic shift in thinking around processes, that will occur slowly as companies are forced to deal with market-shaping factors.